RSG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
RSG is not a good buy right now for an impatient buyer. The setup is only mildly attractive technically (near support with RSI ~37), but there are no Intellectia buy signals, recent insider selling is heavy, Congress trading is all sells, and analysts have been trimming price targets into the upcoming earnings event (2026-02-17). I would hold/avoid new entries today rather than buy immediately.
Price/Trend: RSG at 212.11 (-1.13%) is trading below the pivot (214.386), indicating near-term weakness. Support sits at S1 209.855 (then S2 207.056); resistance is 218.916 then 221.715. Momentum: MACD histogram is positive (0.248) but contracting, suggesting upside momentum is fading rather than accelerating. RSI(6) at 36.691 is near the lower end of neutral (approaching oversold), which can support a short-term bounce, but it is not a strong buy signal by itself. Moving averages are converging, consistent with a choppy/sideways-to-slightly-down phase rather than a clean uptrend.
Intellectia Proprietary Trading Signals
Tactical read: A bounce is plausible if 209.9 holds, but without a proprietary buy trigger, the risk/reward for buying immediately is only متوسط (not compelling).
Technical: RSI near ~37 and proximity to support (209.
could spark a short-term mean-reversion bounce.
Options positioning is mildly bullish (call-leaning put/call ratios).
Defensive business profile in waste services often holds up relatively well in weaker tape (S&P 500 down -0.53% today).
Potential earnings catalyst upcoming: QDEC 2025 earnings on 2026-02-17 after hours could reset expectations if pricing/cost spread commentary is strong.
Insider activity: Insiders are selling, with selling amount up ~2785% over the last month—clear negative signal on near-term confidence.
Congress trading (last 90 days): 4 sells, 0 buys (median ~$0.8M), reinforcing a cautious sentiment from influential traders.
Analyst target cuts are clustering recently (Citi, BofA, Barclays, Scotiabank, Oppenheimer), suggesting valuation/near-term upside is getting compressed.
Fundamentals: margin and earnings pressure (EPS, net income, gross margin down YoY) reduces the case for chasing the stock without a clearer technical uptrend.
MACD positive but contracting + price below pivot implies momentum is weakening rather than improving.
Latest reported quarter: 2025/Q3. Revenue grew to $4.212B (+3.33% YoY), but profitability softened: net income $550M (-2.78% YoY), EPS 1.76 (-2.22% YoY), and gross margin 30.63% (-3.01% YoY). Takeaway: top-line growth is steady, but margins/earnings are drifting lower, which fits with the recent wave of trimmed price targets.
Recent trend: Mostly stable ratings (Buy/Outperform/Equal Weight/Sector Perform/Market Perform) but with a clear pattern of price-target trims in January (Oppenheimer 256->255, Scotiabank 246->242, Barclays 237->236, Citi 268->244) and a notable earlier cut by BofA (271->241). Pro view (bull case): strong industry positioning, pricing discipline, vertical integration, and consistent execution (Goldman Buy $255; Citi Buy; BofA Buy). Con view (bear/neutral case): valuation seen as fair/expensive vs peers and recycling/margin headwinds limiting multiple expansion (Bernstein Market Perform; several Equal Weight/Sector Perform stances). Net: Wall Street is constructive on business quality but less enthusiastic on near-term upside at current pricing.
